SLHV St. Louis Heart & Vascular (@SlhvSt) header
SLHV St. Louis Heart & Vascular (@SlhvSt) profile picture

St. Louis Heart & Vascular is a full-service cardiology and vascular practice with 6 practice locations in the St. Louis Metro Area, on both sides of the river.

St Louis, MO
Joined November 2018
Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)Photo by SLHV St. Louis Heart & Vascular (@SlhvSt)
New #DeBakeyCVJournal case report! Heart on Fire: Unmasking RyR2 Mutation in Stress-Induced Ventricular Arrhythmias @DoctorSharmaMD Vishakha Maheshwari, Thirugnanasambandam Thayumanavan, Akshat Sahai, Surender Singh, Biswajit Kar @UTHealthHouston @SlhvSt doi.org/10.14797/mdcvj.1560
4
7
841
SLHV St. Louis Heart & Vascular retweeted
Wow, just wow.
538
2,301
242
6,370
319,191
SLHV St. Louis Heart & Vascular retweeted
🚨 KETO-CTA: A Teachable Moment in Scientific Transparency - - - What happens when a highly publicized study FAILS to report its primary outcome? The KETO-CTA study, designed to evaluate the impact of diet-induced hypercholesterolemia on coronary plaque progression, has sparked interest—and concern. Despite preregistering % change in non-calcified plaque volume (ΔNCPV) as the primary endpoint (see image below), the investigators did not report this outcome directly in the manuscript. Instead, results appeared later...in a social media meme. 🔍 Why it matters: Non-calcified plaque progression is not a trivial metric—it’s the most relevant measure of early atherosclerotic risk. In KETO-CTA, ΔNCPV was +18.8 mm³ in one year (according to the lead investigator--see below), a rate typically associated with much higher-risk cohorts (e.g., familial hypercholesterolemia or diabetes). This was a study of supposedly "low-risk" individuals. 📉 Additional limitations include: 🔹 Short follow-up (1 year): Too brief to reliably detect meaningful progression in low-risk populations. Most longitudinal plaque imaging studies span 3–6 years. 🔹 Lack of control group: No comparator arm to contextualize imaging findings or isolate effects of diet-induced hypercholesterolemia. 🔹 Historical controls misapplied: Cross-study comparisons without accounting for differences in baseline risk, imaging protocols, or statistical methods. 🧠 This isn’t just about one study. When primary outcomes vanish from manuscripts, it erodes trust. When clinical implications are downplayed, we risk misleading patients. The duty to report results transparently isn't optional—it’s foundational to scientific integrity. Let’s be clear: ketogenic diets may offer benefits in select cases. But studies evaluating their cardiometabolic effects must be held to the same rigorous standards applied to all clinical research. In this case, the investigators appear to have fallen short—and possibly engaged in selective or misleading reporting to obscure unfavorable outcomes. 📣 We need better, not louder. We need data, not dodges. Most importantly, we need to treat scientific integrity as non-negotiable. STUDY: jacc.org/doi/10.1016/j.jacad… #EvidenceBasedMedicine #KetoCTA #Cardiology #ResearchEthics #ScientificIntegrity #PreventiveCardiology
24
61
12
274
61,871
SLHV St. Louis Heart & Vascular retweeted
Thank you @emilyswlau for an excellent review of the cardiovascular changes in women at menopause! She says We are not meeting the needs of our menopause women patients! @MGHWomenHeart @harvardmed
1
5
29
1,499
SLHV St. Louis Heart & Vascular retweeted
HUGE congratulations to Drs. Bhola Rama, Harvey Serota, and Mohsin Alhaddad on being recognized as TOP 2021 HFC/HFSA PIs of the year for their significant contributions to the #EMPERORpreserved trial!! @SLHVST @ApexCardio @HFSA Full list of winners: 🔗👇 hfcollaboratory.com/awards/
1
2
6
SLHV St. Louis Heart & Vascular retweeted
To the 6.2 million women and men of America’s hospitals and health systems, thank you for all that you do for your patients and communities. Happy National #HospitalWeek! ow.ly/cK5y30oErsS
2
66
10
87
SLHV St. Louis Heart & Vascular retweeted
#MOACC18 Dr Das discussing the Ceap classification and treatment of venous insufficiency @SlhvSt @MissouriACC
2
2
SLHV St. Louis Heart & Vascular retweeted
Replying to @SlhvSt
Calcium Specks May Help Detect Heart Disease in South Asians | UC San Francisco #CardioTwitter #cac ucsf.edu/news/2019/01/413006…
1
1
SLHV St. Louis Heart & Vascular retweeted
Replying to @SlhvSt
An important video which highlights sudden cardiac death & the importance of bystander #CPR to save lives and #prevention of heart disease. Promote #awareness. This is why we do what we do every day #ILookLikeACardiologist #Cardiology #Cardiologist 👩‍⚕️ m.youtube.com/watch?v=WygYk8…
1
1
SLHV St. Louis Heart & Vascular retweeted
cvent.com/d/qZ087Qix1UG9FruR…? #ACCWIC #ACCFIT #ACCEC @WicBot @MissouriACC @ACCinTouch @akates1 @aartisdalal @IbrahimMSaeed1 @joshmitchellmd @LisaAlderson2 @mikevalentineMD @MinnowWalsh 🗣👩🏻‍⚕️👨‍⚕️MOACC scientific session in Columbia MO Nov2 for 💎science & meet your colleagues !!
5
8